Carregant...
Long-term outcomes in patients aged 70 years or less with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction: an exploratory analysis.
BACKGROUND AND PURPOSE: We aimed to determine whether subjects aged ≤70 years who were treated with intravenous glyburide (RP-1127; BIIB093; glibenclamide) would have better long-term outcomes than those who received placebo. METHODS: Glyburide Advantage in Malignant Edema and Stroke-Remedy Pharmace...
Guardat en:
| Publicat a: | Stroke |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192530/ https://ncbi.nlm.nih.gov/pubmed/29789393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.020365 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|